560 related articles for article (PubMed ID: 31194953)
21. The association between different hypoglycemic regimens and postoperative diabetic macular edema after vitrectomy in the Japanese patients with proliferative diabetic retinopathy.
Lei C; Zhang Y; Zhang M
Front Endocrinol (Lausanne); 2022; 13():764254. PubMed ID: 35937830
[TBL] [Abstract][Full Text] [Related]
22. Diabetic Macular Edema: Traditional and Novel Treatment.
Tomić M; Vrabec R; Poljičanin T; Ljubić S; Duvnjak L
Acta Clin Croat; 2017 Mar; 56(1):124-132. PubMed ID: 29120156
[TBL] [Abstract][Full Text] [Related]
23. [Diabetic Macular Edema].
Barth T; Helbig H
Klin Monbl Augenheilkd; 2021 Sep; 238(9):1029-1043. PubMed ID: 34380156
[TBL] [Abstract][Full Text] [Related]
24. Recent advances in management of diabetic macular edema.
Tripathy K; Sharma YR; R K; Chawla R; Gogia V; Singh SK; Venkatesh P; Vohra R
Curr Diabetes Rev; 2015; 11(2):79-97. PubMed ID: 25801496
[TBL] [Abstract][Full Text] [Related]
25. Association of Abnormal Renal Profiles and Proliferative Diabetic Retinopathy and Diabetic Macular Edema in an Asian Population With Type 2 Diabetes.
Hsieh YT; Tsai MJ; Tu ST; Hsieh MC
JAMA Ophthalmol; 2018 Jan; 136(1):68-74. PubMed ID: 29167896
[TBL] [Abstract][Full Text] [Related]
26. Cost-effectiveness of Intravitreous Ranibizumab Compared With Panretinal Photocoagulation for Proliferative Diabetic Retinopathy: Secondary Analysis From a Diabetic Retinopathy Clinical Research Network Randomized Clinical Trial.
Hutton DW; Stein JD; Bressler NM; Jampol LM; Browning D; Glassman AR;
JAMA Ophthalmol; 2017 Jun; 135(6):576-584. PubMed ID: 28492920
[TBL] [Abstract][Full Text] [Related]
27. Cost Evaluation of Early Vitrectomy versus Panretinal Photocoagulation and Intravitreal Ranibizumab for Proliferative Diabetic Retinopathy.
Lin J; Chang JS; Yannuzzi NA; Smiddy WE
Ophthalmology; 2018 Sep; 125(9):1393-1400. PubMed ID: 29606379
[TBL] [Abstract][Full Text] [Related]
28. Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy.
Li Y; Yu Y; VanderBeek BL
Eye (Lond); 2020 May; 34(5):934-941. PubMed ID: 31586167
[TBL] [Abstract][Full Text] [Related]
29. Risk of Systemic Adverse Events Associated with Intravitreal Anti-VEGF Therapy for Diabetic Macular Edema in Routine Clinical Practice.
Maloney MH; Schilz SR; Herrin J; Sangaralingham LR; Shah ND; Barkmeier AJ
Ophthalmology; 2019 Jul; 126(7):1007-1015. PubMed ID: 30292542
[TBL] [Abstract][Full Text] [Related]
30. Surgical Innovations in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy.
Berrocal MH; Acaba LA; Chenworth ML
Curr Diab Rep; 2019 Sep; 19(10):106. PubMed ID: 31529405
[TBL] [Abstract][Full Text] [Related]
31. RANIBIZUMAB PLUS PROMPT OR DEFERRED LASER FOR DIABETIC MACULAR EDEMA IN EYES WITH VITRECTOMY BEFORE ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY.
Bressler SB; Melia M; Glassman AR; Almukhtar T; Jampol LM; Shami M; Berger BB; Bressler NM;
Retina; 2015 Dec; 35(12):2516-28. PubMed ID: 26035510
[TBL] [Abstract][Full Text] [Related]
32. Five-Year Outcomes of Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy: A Randomized Clinical Trial.
Gross JG; Glassman AR; Liu D; Sun JK; Antoszyk AN; Baker CW; Bressler NM; Elman MJ; Ferris FL; Gardner TW; Jampol LM; Martin DF; Melia M; Stockdale CR; Beck RW;
JAMA Ophthalmol; 2018 Oct; 136(10):1138-1148. PubMed ID: 30043039
[TBL] [Abstract][Full Text] [Related]
33. Improvement of visual acuity in eyes with diabetic macular edema after treatment with pars plana vitrectomy.
Jahn CE; Töpfner von Schutz K; Richter J; Boller J; Kron M
Ophthalmologica; 2004; 218(6):378-84. PubMed ID: 15564755
[TBL] [Abstract][Full Text] [Related]
34. Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Retinopathy: Consequences of Inadvertent Treatment Interruptions.
Wubben TJ; Johnson MW;
Am J Ophthalmol; 2019 Aug; 204():13-18. PubMed ID: 30878488
[TBL] [Abstract][Full Text] [Related]
35. Management of diabetic retinopathy: a systematic review.
Mohamed Q; Gillies MC; Wong TY
JAMA; 2007 Aug; 298(8):902-16. PubMed ID: 17712074
[TBL] [Abstract][Full Text] [Related]
36. SGLT2 inhibitors and diabetic retinopathy progression.
Nadelmann JB; Miller CG; McGeehan B; Yu Y; VanderBeek BL
Graefes Arch Clin Exp Ophthalmol; 2024 Mar; 262(3):753-758. PubMed ID: 37847267
[TBL] [Abstract][Full Text] [Related]
37. Recent clinically relevant highlights from the Diabetic Retinopathy Clinical Research Network.
Krick TW; Bressler NM
Curr Opin Ophthalmol; 2018 May; 29(3):199-205. PubMed ID: 29528861
[TBL] [Abstract][Full Text] [Related]
38. Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years.
Lundeen EA; Kim M; Rein DB; Wittenborn JS; Saaddine J; Ehrlich JR; Holliday CS
Diabetes Care; 2023 Apr; 46(4):687-696. PubMed ID: 36637915
[TBL] [Abstract][Full Text] [Related]
39. Yearly Treatment Patterns for Patients with Recently Diagnosed Diabetic Macular Edema.
Moulin TA; Adjei Boakye E; Wirth LS; Chen J; Burroughs TE; Vollman DE
Ophthalmol Retina; 2019 Apr; 3(4):362-370. PubMed ID: 31014689
[TBL] [Abstract][Full Text] [Related]
40. [Treatment of sight-threatening diabetic retinopathy].
Grauslund J
Ugeskr Laeger; 2018 Jul; 180(31):. PubMed ID: 30064622
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
